Variation Biotech Raises $35.7 Million

Variation Biotechnologies Inc., an Ottawa, Canada-based maker of vaccines for infectious diseases, has raised US$35.7 million in Series A funding. Clarus Ventures led the deal, and was joined by Arch Venture Partners, 5AM Ventures and certain seed backers. www.variationbiotech.com